KAERN, Mads
$364,376.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2013-2014
Canada
Defining the causes of heterogeneous riboucleotide reductase gene transcription in response to DNA damage and anti-cancer drugs